ORIGINAL PAPER
Evaluation of metabolic score for insulin resistance index as a sensitive marker of insulin resistance and its ability to predict hepatic steatosis in obese children and adolescents. A pilot study
 
More details
Hide details
1
Paediatrics Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
 
2
Clinical and Chemical Pathology Department, Medical Research and Clinical Studies Institute, National Research Centre, Cairo, Egypt
 
 
Submission date: 2024-04-04
 
 
Final revision date: 2024-06-22
 
 
Acceptance date: 2024-07-16
 
 
Publication date: 2024-09-30
 
 
Corresponding author
Abeer M. Nour ElDin Abd ElBaky
Paediatrics Department, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt
 
 
Pediatr Pol 2024;99(3):203-210
 
KEYWORDS
TOPICS
ABSTRACT
Introduction::
The metabolic score for insulin resistance (METS-IR) index could be a sensitive marker of insulin resistance and might predict hepatic steatosis in obese children. The aim of the study was to evaluate the METS-IR index as a sensitive marker of insulin resistance and its ability to predict hepatic steatosis in obese children and adolescents.

Material and methods::
A cross-sectional study was conducted with 190 subjects: 50 normal weight, 50 with overweight, and 90 children with obesity. All subjects underwent measurements of height, body weight, body mass index (BMI), waist and hip circumference, and blood pressure. A blood sample was taken for assessment of lipid profile, fasting blood glucose and insulin, and liver enzymes. The homeostatic model assessment for insulin resistance (HOMA-IR), triglyceride-glucose (TyG) index, and METS-IR index were calculated. Abdominal ultrasonography was done to search for fatty liver, to measure subcutaneous fat thickness and visceral fat thickness (VFT). Children were classified into a hepatic steatosis group and a group without hepatic steatosis.

Results::
Body mass index, waist hip ratio, body fat percentage, subcutaneous fat thickness, visceral fat, alanine aminotransferase, METS-IR, and TyG index were significantly higher in the hepatic steatosis group than in the group without hepatic steatosis. The metabolic score for insulin resistance was the best independent predictor for hepatic steatosis.

Conclusions::
The metabolic score for insulin resistance is a sensitive marker of IR among obese children and adolescents and was found to be a strong predictor for hepatic steatosis. The metabolic score for insulin resistance index has significant and positive correlations with ΗΟΜΑ-IR, TyG index, VFT, fasting insulin, and BMI. It could be a used as a screening tool for hepatic steatosis.
REFERENCES (34)
1.
Yazıcı D, Sezer H. Insulin resistance, obesity and lipotoxicity. Adv Exp Med Biol 2017; 960: 277-304.
 
2.
Kelishadi R, Cook SR, Motlagh ME, et al. Metabolically obese normal weight, and phenotypically obese metabolically normal youths: the CASPIAN study. J Am Diet Assoc 2008; 108: 82-90.
 
3.
Teixeira D, Martins C, Oliveira G, Soares R. Metabolically healthy obesity in a paediatric obesity clinic. J Pediatr Endocrinol Metabol 2022; 35: 1147-1153.
 
4.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
 
5.
Gołacki J, Matuszek M, Matyjaszek-Matuszek B. Link between insulin resistance and obesity – from diagnosis to treatment. Available from: http://dx.doi.org/10.3390/diag....
 
6.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord 2008; 6: 299-304.
 
7.
Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism 2021; 119: 15476.
 
8.
Li Chan TJX, Ting ting W, Fei H, Jian Jun L. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol 2022; 21: 68.
 
9.
Dikaiakou E, Vlachopapadopoulou EA, Paschou SA, et al. Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents. Endocrine 2020; 70: 58-64.
 
10.
Yoon JS, Shim YS, Lee HS, Hwang IT, Hwang JS. A population-based study of TyG index distribution and its relationship to cardiometabolic risk factors in children and adolescents. Sci Rep 2021; 11: 1-9.
 
11.
Zhang S, Du T, Jianhua Zhang, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis 2017; 16: 15.
 
12.
García AG, Treviño MVU, Sánchez DCV, Aguilar CA. Diagnostic accuracy of triglyceride/glucose and triglyceride/HDL index as predictors for insulin resistance in children with and without obesity. Diabetes Metab Syndr 2019; 13: 2329-2334.
 
13.
Moon S, Park JS, Ahn Y. The cut-of values of triglycerides and glucose index for metabolic syndrome in American and Korean adolescents. J Korean Med Sci 2017; 32: 427-433.
 
14.
Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol 2018; 178: 533-444.
 
15.
Yoon J, Jung D, Lee Y, et al. The metabolic score for insulin resistance (METS-IR) as a predictor of incident ischemic heart disease: a longitudinal study among Korean without diabetes. J Pers Med 2021; 11: 742.
 
16.
Fan J, Gao ST, Wang LJ, et al. Association of three simple insulin resistance indexes with prehypertension in normoglycemic subjects. Metab Syndr Relat Disord 2019; 17: 374-379.
 
17.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, American Gastroenterological Association, American Association for the Study of Liver Diseases, American College of Gastroenterologyh. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology 2012; 142: 1592-1609.
 
18.
Egyptian growth curves (2009) diabetes endocrine metabolism pediatric unit Cairo university children’s hospital. Avaulable from: http://dempuegypt.blogspot.com....
 
19.
Deurenberg P, Weststrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr 1991; 65: 105-114.
 
20.
Valls C, Iannacconne R, Alba E, et al. Fat in the liver: diagnosis and characterization. Eur Radiol 2006; 16: 2292-308.
 
21.
Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 745-750.
 
22.
Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115: e561-e565.
 
23.
Imanzadeh F, Olang B, Sayyari AA, et al. Prevalence and related factors for non-alcoholic fatty liver disease in obese students. J Compr Ped 2023.
 
24.
Tominaga K, Fujimoto E, Suzuki K, et al. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Env Health Prevent Med 2009; 14: 142-149.
 
25.
Gupta R, Bhangoo A, Matthews N, et al. The prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children. JPEM 2011; 24: 907-911.
 
26.
Penke M, Kiess W, de Giorgis T. Non-alcoholic fatty liver disease in children and adolescents J Pediatr Endocrinol Metab 2016; 29: 1329-1330.
 
27.
Bugianesi E, Gastaldelli A, Vanni E, et al. Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 2005; 48: 634-642.
 
28.
Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr 1997; 24: 317-321.
 
29.
Locateli JC, Lopes WA, Simoes CF, et al. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in South American overweight and obese children and adolescents. J Pediatr Endocrinol Metab 2019; 32: 1163-1170.
 
30.
Simental-Mendia LE, Hernandez-Ronquillo G, Gomez-Diaz R, Rodriguez-Moran M, Guerrero-Romero F. The triglycerides and glucose index is associated with cardiovascular risk factors in normalweight children and adolescents. Pediatr Res 2017; 82: 920-925.
 
31.
Lee JH, Kwon YJ, Park K, et al. Metabolic score for insulin resistance is inversely related to incident advanced liver fibrosis in patients with non-alcoholic fatty liver disease. Nutrients 2022; 14: 30-39.
 
32.
Lee JH, Park K, Lee HS, Park HK, Han JH, Ahn SB. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin Mol Hepatol 2022; 28: 814-826.
 
33.
Kim SS, Cheong JY. Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: potential benefits and limitations. Clin Mol Hepatol 2022; 28: 802-805.
 
34.
Soon Sun K, Jae YC. Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations. Clin Mol Hepatol 2022; 28: 802-805.
 
Journals System - logo
Scroll to top